Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants.

scientific article published on July 2009

Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BBMT.2009.03.018
P932PMC publication ID2721718
P698PubMed publication ID19539218
P5875ResearchGate publication ID26304026

P50authorEls GoulmyQ1965129
Edus H WarrenQ37842175
Stephen SpellmanQ111077182
P2093author name stringTao Wang
Michael Haagenson
Bradley C Pietz
Thomas M Ellis
Melissa B Warden
P2860cites workIdentification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigensQ24673417
The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processingQ24675797
The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoproteinQ28187004
Recognition of a B cell leukemia-associated minor histocompatibility antigen by CTL.Q30179443
A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia.Q30274634
The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein.Q30307859
UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition.Q33922834
Molecules and mechanisms of the graft-versus-leukaemia effectQ34318010
High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantationQ34582448
Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemiaQ34808353
The current status of hematopoietic cell transplantationQ34987985
The immunogenomics of minor histocompatibility antigens.Q35030963
Multiplexed genetic analysis using an expanded genetic alphabetQ35070311
Phenotype frequencies of autosomal minor histocompatibility antigens display significant differences among populationsQ35865440
Using expanded genetic alphabets to simplify high-throughput genetic testingQ36411692
The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism.Q41061835
Multiple minor histocompatibility antigen disparities between a recipient and four HLA-identical potential sibling donors for bone marrow transplantationQ41537736
Much ado about minor histocompatibility antigensQ41737638
Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimenQ44370136
CD31 mismatching affects marrow transplantation outcome.Q45936737
Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcomeQ47359749
Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.Q54684597
Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leuQ57219125
Minor histocompatibility antigens, defined by graft-vs.-host disease-derived cytotoxic T lymphocytes, show variable expression on human skin cellsQ68321746
Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantationQ68809214
Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donorsQ70051817
Isolation of an HLA-A2.1 extracted human minor histocompatibility peptideQ70599533
Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantationQ70812614
Minor histocompatibility antigens HA-1-, -2-, and -4-, and HY-specific cytotoxic T-cell clones inhibit human hematopoietic progenitor cell growth by a mechanism that is dependent on direct cell-cell contactQ72656176
Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantationQ73070294
DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejectionQ73386767
Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT)Q73876956
T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificitiesQ73877066
The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantationQ80860433
Donor CD31 genotype impacts on transplant complications after human leukocyte antigen-matched sibling allogeneic bone marrow transplantationQ81490638
Minor histocompatibility antigen HA-8 mismatch and clinical outcome after HLA-identical sibling donor allogeneic stem cell transplantationQ81579273
Multiplex genotyping of human minor histocompatibility antigensQ83003340
P433issue7
P921main subjectstem cell transplantationQ65592366
P304page(s)856-863
P577publication date2009-07-01
P1433published inBiology of Blood and Marrow TransplantationQ15754328
P1476titleEffects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants
P478volume15

Reverse relations

cites work (P2860)
Q36279223Association between genetic variants in adhesion molecules and outcomes after hematopoietic cell transplants
Q39425522Association between single nucleotide polymorphisms of tumor necrosis factor gene and grade II-IV acute GvHD: a systematic review and meta-analysis
Q36556944Association of disparities in known minor histocompatibility antigens with relapse-free survival and graft-versus-host disease after allogeneic stem cell transplantation
Q38123020Biologic markers of chronic GVHD.
Q35094374Biomarkers in chronic graft-versus-host disease
Q37014401CD8+ effector T cells at the fetal-maternal interface, balancing fetal tolerance and antiviral immunity.
Q38021811Developments in the prevention of transfusion-associated graft-versus-host disease
Q34393959Does minor histocompatibility antigen HA-1 disparity affect the occurrence of graft-versus-host disease in tunisian recipients of hematopoietic stem cells?
Q37114320Dynamical System Modeling to Simulate Donor T Cell Response to Whole Exome Sequencing-Derived Recipient Peptides Demonstrates Different Alloreactivity Potential in HLA-Matched and -Mismatched Donor-Recipient Pairs.
Q36305321Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT
Q42432554Favorable outcomes in patients with high donor-derived T cell count after in vivo T cell-depleted reduced-intensity allogeneic stem cell transplantation
Q39263959From genetic single candidate gene studies to complex genomics of GvHD.
Q34771143Graft-vs-tumor effect in patients with advanced nasopharyngeal cancer treated with nonmyeloablative allogeneic PBSC transplantation
Q35794126HLA mismatch direction in cord blood transplantation: impact on outcome and implications for cord blood unit selection
Q98906910Human immunology and immunotherapy: main achievements and challenges
Q38171067Immunotherapeutic approaches to treat multiple myeloma
Q34462528In silico Derivation of HLA-Specific Alloreactivity Potential from Whole Exome Sequencing of Stem-Cell Transplant Donors and Recipients: Understanding the Quantitative Immunobiology of Allogeneic Transplantation
Q43434851Increased severity of acute graft versus host disease as a result of differential expression following a homozygous gene deletion
Q38616461Minor histocompatibility Ags: identification strategies, clinical results and translational perspectives
Q43547709Minor histocompatibility antigen HA-1 and HA-2 polymorphisms in Taiwan: frequency and application in hematopoietic stem cell transplantation
Q38254976Minor histocompatibility antigens: past, present, and future.
Q39445130Mismatch for the minor histocompatibility antigen HA-2 and GVHD occurrence in HLA-A*0201-positive Tunisian recipients of HSCs.
Q34044024NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Tr
Q35969119One-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typing
Q42699915Single step multiple genotyping by MALDI-TOF mass spectrometry, for evaluation of minor histocompatibility antigens in patients submitted to allogeneic stem cell transplantation from HLA-matched related and unrelated donor
Q51536134The impact of H-Y mismatches on results of HLA-matched unrelated allogeneic hematopoietic stem cell transplantation.
Q35153382Whole exome sequencing to estimate alloreactivity potential between donors and recipients in stem cell transplantation